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The antioxidantandantinociceptive activities ofCitrus limon essentialoil(EO)were assessedinmice orin vitro tests.EOpossesses
a strong antioxidantpotential according to the scavengingassays.Moreover, it presented scavenger activity against all in vitro tests.
Orally, EO (50, 100, and 150mg/kg) signiﬁcantly reduced the number of writhes, and, at highest doses, it reduced the number of
pawlicks.WhereasnaloxoneantagonizedtheantinociceptiveactionofEO(highestdoses),thissuggested, atleast,theparticipation
of the opioid system. Further studies currently in progress will enable us to understand the action mechanisms of EO.
1.Background
The plants of the family Rutaceae comprise 150 genera with
approximately 2.000 species, the largest of which are Citrus
(about 70 species) and Terminalia (about 200 species) [1].
Some species of Citrus have a broad spectrum of biological
activities, includingantibacterial,antiviral, antioxidant, anti-
fungal, analgesic, and anti-inﬂammatory [2–4].
Medicinal plants, considered those with therapeutic
properties, have been used since the beginning of human
civilization to treat diﬀerent diseases, and the use of this
eﬀective strategy for the promotion of human health has
signiﬁcantly increased in recent years as notable progress has
been made concerning the developmentof natural therapies.
Hence, there is an urgent need to discover eﬀective and
potent analgesic and anti-inﬂammatory agents [5–7].
Citrus limon (L.) Burm is a plant from the north
and northeast of Brazil, known by the popular name
of “limoeiro” [8, 9]. Infusions prepared with the aerial
(leaves) parts of Citrus limon are used in folk medicine
for the treatment of obesity, diabetes, blood lipid lowering,
cardiovascular diseases, brain disorders, and certain types of
cancer [10–12].
Free radicals and related reactive species are strongly
involved in several pathological and physiological processes,
including seizures, cancer, cell death, inﬂammation and
pain [13–17]. Many natural products exert signiﬁcant redox
activities, which are related to their therapeutical properties2 Journal of Biomedicine and Biotechnology
or even a possible toxic eﬀect [18]. The evaluation of the
redox properties of such compounds is crucial for both
understanding the potential mechanisms of their biological
actions and determining possible toxic or harmful side-
eﬀects. Considering the lack of experimental evidence and
scientiﬁc investigations about possible therapeutic and/or
redox properties of Citrus limon, the purpose of the present
study was to evaluate the redox properties plus possible
antinociceptive eﬀects of the essential oil obtained from the
leaves of Citrus limon (EO).
Initially, we intend to evaluate the in vitro and in vivo
antioxidant and antinociceptive actions, since there are no
previous studies about them. Further studies are also in
progress to analyze and discover the probable mechanisms
of action of EO.
2.Methods
2.1. Plant Material. Plant material was collected in February
2010, at the city of Picos, State of Piaut, Brazil, and their
voucher was deposited at the Graziela Barroso Herbarium
of the Federal University of Piaut (UFPI) under the voucher
number 26.453. Samples of essential oils from the leaves of
the C. limon were prepared by the Laboratory of Chemistry
of UFPI [19].
2.2. Preparation of EO. The leaves of C. limon were dried in
anovenwithairrenewal andcirculation(modelMA-037/18)
at 40◦C until complete dehydration has been achieved. The
essential oilwas obtainedbyhydrodistillation in aClevenger-
type apparatususing 1.100g of dried leaves. The oil obtained
was dried overanhydrous sodium sulphate, producing yields
of 0.32% (v/w). GC-MS analysis was performed in a GC-
17A/MS QP5050A—GC/MS system (EI mode 70eV, source
temperature 270◦C, scanned mass ranged 43–350amu). The
operating conditions were as follows: DB-5HT (J & W
Scientiﬁc, 30m × 0.25mm i.d. ×0.10μm ﬁlm thickness);
helium as the carrier gas, ﬂow rate of 1.0mL min−1 and with
split ratio of 1: 30; from 60◦C (2min) to 180◦Ca t4 ◦C/min
and then from 180◦C (4min) to 260◦Ca t1 0 ◦C/min, with
a ﬁnal hold of 10min at 260◦C. The identity of each
compound was determined by comparison of its retention
index relative to C8–C20 n-alkanes (Fluka Analytical, 1.0mL
Alkane Standard Solution), as well as of its spectra with the
Wiley 275L database [20, 21]. The retention data (retention
indices) were compared to those of the literature [22, 23].
2.3. Chemicals. Sodium nitroprusside, FeSO4,G r i e s s ’m o d -
iﬁed reagent, 2-deoxyribose, 2-thio-barbituric acid, AAPH
(2,2 -azobis[2-methylpropionamidine]dihydrochloride), tri-
chloroacetic acid, trolox (6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-carboxilic acid), acetic acid, nordihydroguaiaret-
ic acid, and polyoxyethylene-sorbitan monolate (Tween 80)
were purchased from Sigma Co. (USA). Morphine (MOR),
naloxone (NAL), and aspirin (acetylsalicylic acid) were
purchased from Crist´ alia (Brazil). All drugs and the essential
oil were administered orally (o.r.) in volumes of 0.1mL/10g
(mice).
2.4. Thiobarbituric Acid Reactive Species (TBARS) Assay.
TBARS (thiobarbituric acid reactive species) assay was
employedtoquantifylipidperoxidation[24],andanadapted
TBARSmethodwasusedtomeasuretheantioxidantcapacity
of EO using egg yolk homogenate as lipid-rich substrate
[18]. Brieﬂy, egg yolk was homogenized (1%w/v) in 20mM
phosphate buﬀer (pH 7.4); 1mL of homogenate was soni-
cated and then homogenized with 0.1mL of EO at diﬀerent
concentrations. Lipid peroxidation was induced by addition
of 0.1mL of AAPH solution (0.12M). Control was only EO
vehicle(ethanol0.1%).Reactionswerecarriedoutfor30min
at 37◦C. After cooling, samples (0.5mL) were centrifuged
with 0.5mL of trichloroacetic acid (15%) at 1200 × gf o r
10min. An aliquot of 0.5mL from supernatant was mixed
with 0.5mL TBA (0.67%) and heated at 95◦Cf o r3 0 m i n .
After cooling, sample absorbances were measured using a
spectrophotometer at 532nm. The results were expressed
as percentage of TBARS formed by AAPH alone (induced
control).
2.5. Hydroxyl Radical Scavenging Activity. The formation of
OH (hydroxyl radical) from Fenton reaction was quantiﬁed
using 2-deoxyribose oxidative degradation [25]. The prin-
ciple of the assay is the quantiﬁcation of the 2-deoxyribose
degradation product, malondialdehyde, by its condensation
with 2-thiobarbituric acid (TBA). Brieﬂy, typical reactions
were started by the addition of Fe2+ (FeSO4 6mM ﬁnal
concentration) to solutions containing 5mM 2-deoxyribose,
100mM H2O2, and 20mM phosphate buﬀer (pH 7.2). To
measure EO antioxidant activity against hydroxyl radical,
diﬀerent concentrations of EO were added to the system
beforeFe2+ addition.Reactionswerecarriedoutfor15minat
room temperature and were stopped by the addition of 4%
phosphoric acid (v/v) followed by 1% TBA (w/v, in 50mM
NaOH). Solutions were boiled for 15min at 95◦Ca n dt h e n
cooled at room temperature. The absorbance was measured
at 532nm, and results were expressed as MDA equivalents
formed by Fe2+ and H2O2.
2.6. Scavenging Activity of Nitric Oxide (NO). Nitric oxide
was generated from spontaneous decomposition of sodium
nitroprusside in 20mM phosphate buﬀer (pH 7.4). Once
generated, NO interacts with oxygen to produce nitrite
ions, which were measured by the Griess reaction [26].
The reaction mixture (1mL) containing 10mM sodium
nitroprusside (SNP) in phosphate buﬀer and EO at diﬀerent
concentrations was incubated at 37◦C for 1h. A 0.5mL
aliquot was taken and homogenized with 0.5mL Griess
reagent. The absorbance of chromophore was measured at
540nm. Percent inhibition of generated nitric oxide was
measured by comparing the absorbance values of negative
controls(only10mM sodiumnitroprussideand vehicle)and
assay preparations. Results were expressed as percentage of
nitrite formed by SNP alone.
2.7. Animals. Male Swiss mice (25–30g), with 2 months of
age, were used throughout this study divided in randomized
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Figure 2: Thiobarbituric acid-reactive substances (TBARS) in
vitro. A lipid-rich system was incubated with a free radical source
(AAPH) and the eﬀect of diﬀerent concentrations of EO on the
lipoperoxidation was measured by quantifying TBARS. Control is
incubation medium without AAPH; other groups contained AAPH
alone or in the presence of diﬀerent concentrations of EO. Trolox
wasused asstandard antioxidant.Bars represent mean±SEM. aP<
.001, when compared to control; bP<. 001, when compared to
1μg/mL; cP<. 001, when compared to 10μg/mL; dP<. 001, when
compared to 100μg/mL; eP<. 001, when compared to 1mg/mL.
One-way ANOVA followed by Tukey’s multiple comparison post
hoc test was applied to all data.
housed in appropriate cages at 22 ± 1◦Co na1 2hl i g h t / d a r k
cycle(lights on06:00AM–18:00PM) with free access to food
(Purina, S˜ ao Paulo) and tap water. Experimental protocols
and procedures were approved by the Ethics Committee
on Animal Experiments of the Federal University of Piau´ ı
(CEEA/UFPIno. 44/09).
2.8. Acetic Acid-Induced Writhing. This test was done using
the method previously described [27, 28]. Initially the mice
were divided into ﬁve groups (n = 7). Subsequently, EO (50,
100, and 150mg/kg), vehicle (saline/Tween-80 0.5%; control
group), and morphine (MOR, 5mg/kg) were administered
orally (o.r.) 60min before an injection of 0.85% acetic acid
(0.25mL/animal). Each animal was isolated in an individual
observation chamber and 15min after acetic acid injection
the cumulative number of writhing responses was recorded
during 15min.
2.9. Formalin Test. The animals were divided into six groups
(n = 7) and treated o.r. with vehicle (control), EO (50, 100,
and 150mg/kg), MOR (5mg/kg), and 200mg/kg of aspirin.
After 60min, twenty microliters of a 2.5% formalin solution
(0.92% formaldehyde) in a phosphate buﬀer (pH 7.2) were
injected into the dorsal surface of the left hind paw using a
microsyringe with a 26-gauge needle [29]. The duration of
paw licking was measured at 0–5min (ﬁrst phase) and 15–
30min (second phase) after formalin administration.
2.10. Possible Antagonism of the EO Antinociceptive Eﬀect
by Pretreatment with Naloxone. Mice were i.p. pretreated
(n = 7) with 1.5mg/kg of naloxone (NAL), a nonselective
opioid antagonist, 15min before the o.r. administration
of vehicle (control), EO (150mg/kg), or MOR (5mg/kg).
Subsequently, the acetic acid-induced writhing test was
performed as described above.
2.11. Hot Plate Test. In this test, reaction of mice to painful
stimulus was measured. Mice were placed individually on
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Figure 3: Nitric oxide (NO) scavenging assay. Nitric oxide is
generated from spontaneous decomposition of sodium nitroprus-
side (SNP) and interacts with oxygen to produce nitrite ions,
which are measured by the Griess reaction. SNP group is sodium
nitroprusside alone other groups denote nitrite production by SNP
in the presence of diﬀerent concentrations of EO. Bars represent
mean ± SEM. aP<. 001, when compared to control; bP<
.001, when compared to 1μg/mL; cP<. 001, when compared to
10μg/mL; dP<. 001, when compared to 100μg/mL. One-way
ANOVA followed by Tukey’s multiple comparisonpost hoc test was
applied to all data.
glass cylinder (25cm high, 15cm in diameter). The time (s)
elapsing to the ﬁrst pain response (licking of the forepaws or
jumping) was determined by a stopwatch and then recorded
[30]. The experiments were conducted 60 min following the
o.r. administration of the EO (50, 100, and 150mg/kg). The
eﬀect of pretreatment with naloxone (1.5mg/kg, i.p.) on the
antinociception produced by EO (150mg/kg) and morphine
(5mg/kg, i.p.) was determined.
2.12. RotaRod Test. Initially, the mice able to remain on the
Rotarod apparatus (AVS, Brazil) longer than 180s (9rpm)
were selected 24h before the test [31]. Then, the selected
animals were divided into ﬁve groups (n = 7) and treated
i.p. with vehicle (control), EO (50, 100, and 150mg/kg), and
diazepam (3mg/kg). Thirty minutes later, each animal was
tested on the Rotarod, and the time (s) they remained on the
b a rf o ru pt o1 8 0sw a sr e c o r d e da f t e r6 0m i n .
2.13. Statistical Analysis. The obtained data was evaluated
by one-way analysis of variance (ANOVA) followed by
Dunnett’s and Tukey’s tests. In all cases, diﬀerences were
consideredsigniﬁcant ifP<. 05.The percent ofinhibition by
an antinociceptive agent was determined for the acetic acid-
induced writhing and formalin tests using the following for-
mula: inhibition % = 100 × (control−experiment)/control
[32].
3.Results
GC-MS analysis showed a mixture of monoterpenes, being
limonene (52.77%), geranyl acetate (9.92%) and trans-
limonene-oxide(7.13%)themain compoundsin essential oil
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Figure 4: Hydroxyl radical scavenging activity. Hydroxyl radical
scavenging activity was quantiﬁed using 2-deoxyribose oxidative
degradation in vitro, which produces malondialdehyde by conden-
sationwith2-thiobarbituricacid(TBA).SystemisMDAproduction
from2-deoxyribosedegradationwithFeSO4 andH2O2 alone.Other
groupsdenoteMDAproductionby FeSO4 andH2O2 inthepresence
ofdiﬀerent concentrationsofEO. Barsrepresent mean ± SEM.Bars
represent mean ± SEM. aP<. 001, when compared to control;
bP<. 001, when compared to 1μg/mL; cP<. 001, when compared
to 10μg/mL; dP<. 001, when compared to 100μg/mL; eP<. 001,
when compared to 1mg/mL. One-way ANOVA followed by Tukey’s
multiple comparisonpost hoc test was applied to all data.
Table 1:Eﬀects ofessentialoil(EO) ofC. limon,morp hine(MOR ),
and naloxone (NAL) on writhing induced by acetic acid.
Treatment Dose (mg/kg) No. of
writhings∗ % inhibition
Vehicle — 14.6 ± 2.7 —
EO 50 3.7 ± 0.6a 75
EO 100 3.6 ± 0.82a 76
EO 150 2.9 ± 0.9a,b,c 81
EO plus NAL 150 + 1.5 10.5 ± 1.7a,d 27
MOR 5 1.6 ± 0.5a 91
MOR plus NAL 5 + 1.5 11.2 ± 1.9e,f 23
n = 7p e rg r o u p .
∗Values represent mean ± SEM.
aP<. 01,signiﬁcantlydiﬀerent fromcontrol, bP<. 01,signiﬁcantlydiﬀerent
from EO 50 group, cP<. 01, signiﬁcantly diﬀerent from EO 100group.
dP<. 01, signiﬁcantly diﬀerent from EO 150group, eP<. 01, signiﬁcantly
diﬀerent from EO plus NAL group, fP<. 01, signiﬁcantly diﬀerent from
MOR group. One-way ANOVA followed by Dunnett’s test was applied to all
data.
Quantiﬁcation of TBARS demonstrated that EO exerts a
signiﬁcant antioxidant eﬀect against peroxyl radicals gener-
ated by AAPH, protecting lipids from oxidation, especially
at the highest dose (Figure 2). Trolox (300μM), a synthetic
analogue of vitamin E, which protects membrane from
oxidative damage in vivo, was used as a general antioxidant
standard for comparison.
We next investigated the antioxidant potential of EO
against two diﬀerent reactive species in vitro.E Od e m o n -
strated to exert a signiﬁcant scavenging eﬀect against NO,
but lower concentrations reversed this NO-inhibiting eﬀectJournal of Biomedicine and Biotechnology 5
Table 2: Eﬀect of essential oil (EO) of Citrus limon, morphine (MOR) and aspirin on formalin-induced pain.
Treatment Dose (mg/kg)
No. of licks (s)
0–5min 15–30min
Score of pain∗ % inhibition Score of pain∗ % inhibition
Vehicle — 62.06.2± —6 4 .0 ±11.2—
EO 50 55.1 ±6.6a 11 63.4 ±9.11 1
EO 100 39.9 ±9.8a,b 36 9.1 ± 4.4a,b 85
EO 150 11.8 ±1.9a,b,c 81 5.2 ±0.4a,b,c 92
MOR 5 2.95 ±0.9a 95 3.89 ±0.1a 94
Aspirin 200 45.4 ± 9.8a,d 27 4.9 ±0.6a,d 92
n = 7p e rg r o u p .
∗Values represent mean ± SEM.
aP<. 01, signiﬁcantly diﬀerent from control, bP<. 01, signiﬁcantly diﬀerent from EO 50 group, cP<. 01, signiﬁcantly diﬀerent from EO 100 group, dP<
.001, signiﬁcantly diﬀerent from MOR group. One-way ANOVA followed by Dunnett’s test was applied to all data.
and led to a small increase in NO production, as compared
to higher concentrations (Figure 3).
On the other hand, EO had a strong scavenging eﬀect
against hydroxyl radicals generated in vitro, especially at the
highest doses (Figure 4).
In the acetic acid-induced writhing test, the antinocicep-
tive eﬀect represented by writhe reductionand elicited by 50,
100and 150mg/kgofEO(3.7 ± 0.6,3.5 ± 0.82and 2.9 ± 0.9,
resp.) in mice was similar to thatofmorphine 5mg/kg(1.6 ±
0.5), a standard opioid drug, when groups were compared to
control (14.6 ± 2.7) (Table 1). It was observed that naloxone
(1.5mg/kg, i.p.) antagonized the antinociceptive response of
morphinefrom1.6±0.5(withvehicleonly)to11.2±1.9(with
vehicle plus naloxone) writhes in the acetic acid-induced
writhing test. Similarly, naloxone antagonized the eﬀect of
EO (150mg/kg) (10.5 ± 1.7) when compared to control
(Table 1).
EO signiﬁcantly inhibited the licking response to the
injected paw when 50, 100, or 150mg/kg were administered
orallyinmiceascomparedtothecontrolgroup(62.0±6.2s)
in the ﬁrst phase of the formalin test, at dose-dependent
fashion (Table 2). However, EO (100 and 150mg/kg) sig-
niﬁcantly (P<. 001) inhibited the second phase. As
expected, morphine (5mg/kg) also reduced the licking time
in both phases of this test (2.95±0.9s; 3.89±0.1s), while
aspirin (200mg/kg) reduced it only during the second phase
(4.9±0.6s). EO (50mg/kg) did not produce any signiﬁcant
changes in second phase of the formalin test.
The results suggest that EO (50, 100, and 150mg/kg, i.p.)
has a central analgesic eﬀect (Table 3), as evidenced by the
prolonged delay in response time when mice were subjected
to a nociceptive stimulus during a hot plate test.
In the Rotarod test, EO-treated mice did not show
any signiﬁcant motor performance alterations with the
doses of 50 and 100mg/kg (data not shown). As might
be expected, the CNS depressant diazepam (2mg/kg, i.p.)
reduced the time of treated animals on the rotarod after
60min (77.43±2.08s) as compared to the control group
(177.0±1.45s) (P<. 0001). In this test, 30 days after
administration of essential oil of Citrus limon only in
the group of 150mg/kg (o.r.) (125.0±0.96s) dose, the
remaining time of animals on the Rotarod apparatus was
signiﬁcantly reduced in 30% (P<. 001).
4.Discussion
Membrane lipids are the most susceptible target of free
radicals attack and propagation in biological systems [33].
Additionally, free radicals and related reactive species are
strongly involved in several pathological and physiological
processes, including cancer, cell death, inﬂammation, and
pain [26, 34]. Thus, we assessed the antioxidant potential of
EO by testing its ability to prevent oxidative damage to lipids
induced by a free radical source in vitro (AAPH).
Therefore, it is possible that essential oil interacts more
strongly with speciﬁc types of lipids, and in a lipid-rich
system such as in the TBARS assay lipids with lesser aﬃnity
to essential oil and/or hydrophilic portions of amphipathic
lipids are more susceptible to radical attack, allowing the
initiation of lipoperoxid a t i o nc h a i nr e a c t i o n[ 18].
These results suggest that the protection against lipoper-
oxidation chain reactions observed in TBARS assay is
probablyduetointeractionofEOcomponentswithhydroxyl
radicals, which is a reactive oxygen species (ROS), instead
of with NO, which is a reactive nitrogen species (RNS).
Although EO demonstrated an NO scavenging eﬀect at
certain concentrations, some of its components probably
enhance NO production or cancel the eﬀect of NO scav-
engers in EO when present at higher concentrations. Shifts
from antioxidant to pro-oxidant eﬀects against speciﬁc
radicals are common when analyzing complex mixtures such
as plant extracts, since many components present diﬀerent
redox properties depending on their concentrations [18, 26,
33].
Our results show that EO produced a dose-dependent
inhibition of the inﬂammatory pain in mice as determined
by a signiﬁcant reduction in acetic acid-induced abdom-
inal writhing. Acetic acid-induced abdominal constriction
is a standard, simple, and sensitive test for measuring
analgesia induced by both opioids and peripherally acting
analgesics [29]. This test, besides being the most appropriate
antinociceptive model for opioids[35, 36], is also commonly
employed as a visceral inﬂammatory pain model [37]. In6 Journal of Biomedicine and Biotechnology
Table 3: Eﬀects of essential oil (EO) of Citrus limon or morphine (MOR) on the hot plate test in the absence and presence of naloxone in
mice.
Treatment Dose (mg/kg)
Reaction time (licking of the hind paws) (s)∗
B a s a l 0 . 5 h1 h1 . 5 h
Vehicle — 8.5 ±0.87 10.8 ±0.89 10.9 ±0.91 9.7 ±1.6
EO 50 7.8 ±0.77a 10.7 ±0.68 19.7 ±0.45a 14.9 ±1.4a
EO 100 7.1 ± 0.79a,b 10.9 ±0.38 13.6 ± 0.93a,b 18.5 ±1.8a,b
EO 150 6.5 ±0.67a,b,c 12.4 ±0.34a,b,c 12.2 ±1.71a,b,c 18.4 ± 1.0a,
EO plus NAL 150 + 1.5 9.2 ±0.95d 10.0 ±0.85d 11.5 ±0.85 9.2 ±1.1d
MOR 5 8.1 ±0.83 21.9 ±0.65a 25.4 ±1.45a 27.1 ±1.9a
MOR plus NAL 5 + 1.5 6.8 ±0.84 8.4 ±1.1e,f 12.4 ± 1.23e 7.8 ±1.9e,f
n = 7p e rg r o u p .
∗Values represent mean ± SEM.
aP<. 01, signiﬁcantlydiﬀerent from control, bP<. 01, signiﬁcantlydiﬀerent from EO 50 group, cP<. 01, signiﬁcantlydiﬀerent from EO 100 group. dP<. 01,
signiﬁcantly diﬀerent from EO 150 group, eP<. 01, signiﬁcantly diﬀerent from MOR group, fP<. 01, signiﬁcantly diﬀerent from EO plus NAL group. One-
way ANOVA followed by Dunnett’s test was applied to all data.
acetic acid-induced abdominal writhing, pain is elicited by
the injection of an irritant such as acetic acid into the
peritoneal cavity which produces episodes of characteristic
stretching (writhing) movements, and inhibition of the
number of episodes by analgesics is easily quantiﬁable [18,
38]. Central analgesic action of essential oil was suggested
by the blocking eﬀect of naloxone, a speciﬁc antagonist of
morphinomimetic receptors [39].
The advantage of using the formalin model of noci-
ception is that it can discriminate pain in its central and
peripherical components [40, 41]. The test consists of two
diﬀerentphasesseparatedintime:theﬁrstoneisgeneratedin
the periphery through the activation of nociceptive neurons
by the direct action of formalin and the second phase occurs
through the activation of the ventral horn neurons at the
spinal cord level. Morphine, a typical narcotic drug, inhibits
nociception in both phases [42], but drugs with peripheric
action, such as indomethacin and corticosteroids, inhibit
only the second phase. Moreover, drugs like acetylsalicylic
acid and paracethamol, which inhibit prostaglandin synthe-
sis, block only the second phase of the formalin test [29, 43].
The analgesic action presented by EO involves supraspinal as
wellasspinalcomponents,asdemonstratedbytheutilization
of the hot plate test [44].
Our results support that the essential oil of Citrus limon
exhibitsanantioxidantactioninpreventinglipoperoxidation
(probably due to hydroxyl radical scavenging activity) and a
clearantinociceptive activity. Maybe it exerts its antinocicep-
tive eﬀect by central inhibitory mechanisms (opioid system)
and that can be due to changes in motor coordination. This
anti-inﬂammatory activity of the extract may play a role
in action interfering with prostaglandin synthesis and also
might involve redox-mediated mechanisms. Further studies
areinprogressinordertoenableustounderstandtheprecise
action mechanisms of essential oil of Citrus limon.
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